Trials / Completed
CompletedNCT03402594
High Flow Oxygen Therapy and Acute Ischemic Stroke
Effects of High Flow Oxygen Therapy on Oxygen Desaturation Index in Patients With Acute Ischemic Stroke
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hypoxemia is common in acute ischemic stroke and associated with neurological deterioration and mortality. However, the benefit of oxygen therapy is controversial. Severity of stroke may affect the benefit of oxygen supplementation. Abnormal breathing patterns are commonly found among stroke patients and may increase the risk of hypoxemia. High flow nasal cannula (HFNC) has several advantages from controllable fraction of inspired oxygen (FiO2), reduction of nasopharyngeal resistance and positive end expiratory pressure effect. In this study, we aimed to assess the therapeutic effect of HFNC on oxygen desaturation index (ODI) and neurological outcomes in stroke patients with moderate and severe severities, compared with no and low flow oxygen supplementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High flow oxygen | Heated humidified high flow oxygen cannula (Optiflow; temperature of 34°C and fractional inspired oxygen of 0.24) with a flow rate of 20 liter/minute |
| DEVICE | Low flow oxygen | Oxygen cannula with a flow rate of 2 liter/minute |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-03-31
- Completion
- 2017-06-30
- First posted
- 2018-01-18
- Last updated
- 2018-01-18
Source: ClinicalTrials.gov record NCT03402594. Inclusion in this directory is not an endorsement.